Search for: "Daubert v. Merrell Dow Pharmaceuticals, Inc." Results 141 - 160 of 248
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
25 Jan 2012, 6:42 am by emagraken
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 113 S.Ct. 2786 (1993), and discussed in Taylor v. [read post]
24 Dec 2012, 9:58 am by Schachtman
Merrell Dow Pharmaceuticals Inc., 509 U.S. 579 (1993), a case that has been superseded by subsequent cases and a revision to the operative statute, Rule 702. [read post]
3 Mar 2012, 5:36 pm by Schachtman
Merrell Dow Pharm., Inc., 911 F.2d 941, 958-9 (3d Cir. 1990) Daubert v. [read post]
24 Oct 2017, 6:00 am by Anjelica Cappellino
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), which is also codified in Rule 702 of the Federal Rules of Evidence. [read post]
12 May 2011, 8:10 am by lpcprof
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 113 S.Ct. 2786, 125 L. [read post]
28 Apr 2011, 9:12 am by lpcprof
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 113 S.Ct. 2786, 125 L. [read post]
13 May 2020, 2:03 am by Schachtman
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 592 n.10 (1993). [3]  Id., citing Bourjaily v. [read post]
15 Aug 2019, 5:00 am by Anjelica Cappellino
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993) (which sets forth an enumerated list of factors, including general acceptance within the scientific community, to consider when evaluating an expert’s opinion). [read post]
4 Apr 2016, 10:06 pm by Mehjabeen Rahman
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), and its progeny set the standards for the admissibility of expert reports and testimony. [read post]
19 Oct 2017, 6:00 am by Anjelica Cappellino
Merrell Dow Pharmaceuticals, Inc. and its progeny established the governing standard for the admissibility of expert witness testimony in federal courts. [read post]
28 Jul 2015, 11:52 am by Schachtman
Merrell Dow Pharmaceuticals Inc., 43 F.3d 1311, 1320 (9th Cir.), cert. denied 516 U.S. 869 (1995) [Daubert II]. [read post]
31 Mar 2016, 8:09 am by Jetta Sandin and Jay Levine
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), nor did Tyson offer a rebuttal expert witness. [read post]